Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children
NCT: NCT06137560 · ACTIVE_NOT_RECRUITING
Brief Summary
There are two parts to this trial. First, to compare the rate of myopia progression of spectacle films using Spatio Temporal Optic Phase (S.T.O.P.®) technology that provide a dynamic optical cue against single vision spectacle lenses. Second, to compare the rate of myopia progression of spectacle films using S.T.O.P.® technology that provide a dynamic optical cue against spectacle films using S.T.O.P.® technology that provide a static optical cue. A dynamic optical cue is one that changes, and a static optical cue is one that does not change.
Frequently Asked Questions
What is Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children?
Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children is a clinical trial registered under NCT06137560. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06137560?
The current status of NCT06137560 (Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children) is: ACTIVE_NOT_RECRUITING.
When did Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children start?
Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children started on 2023-12-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.